tiprankstipranks
Trending News
More News >
Rocket Pharmaceuticals (RCKT)
NASDAQ:RCKT
US Market
Advertisement

Rocket Pharmaceuticals (RCKT) Drug Pipeline

Compare
1,648 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Rp-A701 Is A Recombinant Viral Vector Composed Of An Aav Serotype Rh.74 (Aavrh.74) Capsid Encapsulating The Transgene, Bcl2-Associated Athanogene 3 (Bag3)
Dilated Cardiomyopathy (Dcm)
Phase I
Not Yet Recruiting
A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
Jul 25, 2025
Rp-A501
Danon Disease
Phase II
Recruiting
A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
Oct 11, 2023
Rp-L301
Pyruvate Kinase Deficiency
Phase I
Completed
Gene Therapy for Pyruvate Kinase Deficiency (PKD)
Sep 24, 2019

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Rocket Pharmaceuticals (RCKT) have in its pipeline
      RCKT is currently developing the following drugs: Rp-A701 Is A Recombinant Viral Vector Composed Of An Aav Serotype Rh.74 (Aavrh.74) Capsid Encapsulating The Transgene, Bcl2-Associated Athanogene 3 (Bag3), Rp-A501, Rp-L301. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis